Potential biomarker for checkpoint blockade immunotherapy and treatment strategy.

MLA

Dong, Zhong-Yi, et al. “Potential Biomarker for Checkpoint Blockade Immunotherapy and Treatment Strategy.” Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 37, no. 4, Apr. 2016, pp. 4251–61. EBSCOhost, https://doi.org/10.1007/s13277-016-4812-9.

APA

Dong, Z.-Y., Wu, S.-P., Liao, R.-Q., Huang, S.-M., & Wu, Y.-L. (2016). Potential biomarker for checkpoint blockade immunotherapy and treatment strategy. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine, 37(4), 4251–4261. https://doi.org/10.1007/s13277-016-4812-9

Chicago

Dong, Zhong-Yi, Si-Pei Wu, Ri-Qiang Liao, Shu-Mei Huang, and Yi-Long Wu. 2016. “Potential Biomarker for Checkpoint Blockade Immunotherapy and Treatment Strategy.” Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine 37 (4): 4251–61. doi:10.1007/s13277-016-4812-9.